AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $405,000 | +45.2% | 8,523 | +10.4% | 0.15% | -55.8% |
Q4 2018 | $279,000 | -62.8% | 7,723 | -44.2% | 0.34% | +13.4% |
Q1 2018 | $751,000 | +0.4% | 13,844 | +10.6% | 0.30% | -18.1% |
Q4 2017 | $748,000 | +11.1% | 12,516 | -9.6% | 0.36% | -47.2% |
Q3 2017 | $673,000 | – | 13,844 | – | 0.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LEVIN CAPITAL STRATEGIES, L.P. | 1,373,542 | $15,658,000 | 1.56% |
DAFNA Capital Management LLC | 289,040 | $3,295,000 | 0.87% |
Integral Health Asset Management, LLC | 250,000 | $2,850,000 | 0.82% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 193,266 | $2,203,000 | 0.80% |
PFM Health Sciences, LP | 2,182,684 | $24,883,000 | 0.73% |
DCF Advisers, LLC | 136,501 | $1,556,000 | 0.69% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,977,020 | $33,938,000 | 0.66% |
NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $3,532,000 | 0.61% |
Rhenman & Partners Asset Management AB | 750,000 | $8,550,000 | 0.60% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,232,600 | $14,052,000 | 0.52% |